日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjögren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial

瑞米替尼(一种选择性强效口服BTK抑制剂)治疗干燥综合征的疗效和安全性:一项随机、双盲、安慰剂对照的II期试验结果

Dörner, Thomas; Kaul, Martin; Szántó, Antónia; Tseng, Jui-Cheng; Papas, Athena S; Pylvaenaeinen, Ilona; Hanser, Malika; Abdallah, Nasri; Grioni, Andrea; Santos Da Costa, Aida; Ferrero, Enrico; Gergely, Peter; Hillenbrand, Rainer; Avrameas, Alexandre; Cenni, Bruno; Siegel, Richard M

First-in-Human Study of the Safety, Pharmacokinetics, and Pharmacodynamics of MHV370, a Dual Inhibitor of Toll-Like Receptors 7 and 8, in Healthy Adults

MHV370(一种 Toll 样受体 7 和 8 的双重抑制剂)在健康成年人中的安全性、药代动力学和药效学的首次人体研究

Shisha, Tamas; Posch, Maximilian G; Lehmann, Jeanette; Feifel, Roland; Junt, Tobias; Hawtin, Stuart; Schuemann, Jens; Avrameas, Alexandre; Danekula, Rambabu; Misiolek, Patrycja; Siegel, Richard; Gergely, Peter

The BACE-1 inhibitor CNP520 for prevention trials in Alzheimer's disease

用于预防阿尔茨海默病的BACE-1抑制剂CNP520试验

Neumann, Ulf; Ufer, Mike; Jacobson, Laura H; Rouzade-Dominguez, Marie-Laure; Huledal, Gunilla; Kolly, Carine; Lüönd, Rainer M; Machauer, Rainer; Veenstra, Siem J; Hurth, Konstanze; Rueeger, Heinrich; Tintelnot-Blomley, Marina; Staufenbiel, Matthias; Shimshek, Derya R; Perrot, Ludovic; Frieauff, Wilfried; Dubost, Valerie; Schiller, Hilmar; Vogg, Barbara; Beltz, Karen; Avrameas, Alexandre; Kretz, Sandrine; Pezous, Nicole; Rondeau, Jean-Michel; Beckmann, Nicolau; Hartmann, Andreas; Vormfelde, Stefan; David, Olivier J; Galli, Bruno; Ramos, Rita; Graf, Ana; Lopez Lopez, Cristina

Development and validation of an ELISA at acidic pH for the quantitative determination of IL-13 in human plasma and serum.

开发和验证酸性 pH 条件下 ELISA 法,用于定量测定人血浆和血清中的 IL-13

Doucet Julie, Zhao An, Fu Jean, Avrameas Alexandre